Clemedi Update Q4 2022
Dear investors, partners, supporters and friends, we closed the year by increasing our marketing efforts. You might have noticed an increased frequency of linkedIn posts, which we kindly ask you to like and repost. Exhibiting at the MEDICA fair brought in a large number of customer leads which we will be following-up and bring to close during 2023. Fundraising We…
Press Release
English Version Schlieren, Switzerland, Munich, Germany, and Vienna, Austria, December 16, 2022 Clemedi AG concludes a license agreement for detecting latent tuberculosis with the Max Planck Society (MPG) and the Medical University of Vienna Clemedi aims to extend its tuberculosis product line to cover latent tuberculosis. This requires the ability to extract M. tuberculosis DNA from a patient’s blood. The…
